About Christopher Kabrhel, MD, MPH

Christopher Kabrhel MD MPH is a practicing emergency physician, Director of the Center for Vascular Emergencies at Massachusetts General Hospital (MGH), Professor of Emergency Medicine at Harvard Medical School and the MGH Endowed Chair in Emergency Medicine. He received his M.D. from the Johns Hopkins University School of Medicine, a Masters in Public Health from the TH Chan Harvard School of Public Health (HSPH) and completed residency at the Harvard Affiliated Emergency Medicine Residency program. Dr. Kabrhel has more than 15 years of experience performing research into the epidemiology, diagnosis, risk stratification and treatment of acute venous thromboembolism. Dr. Kabrhel's research is funded by the National Institutes of Health, as well as private foundations and industry. He coordinates venous thromboembolism research for the Nurses’ Health Study at Channing Network Medicine at the Health Professionals Follow Up Study at HSPH where he focuses on genetic epidemiology and population risk factors for VTE. To further this work, he co-founded the International Network for Venous Thromboembolism research which focuses on the genetic epidemiology of VTE. In addition to epidemiology, his current work focuses on clinical risk-stratification and novel care delivery methods for patients with acute PE. In 2012, Dr. Kabrhel co-founded the MGH Pulmonary Embolism Response Team (PERT), the first such team in the world as well as the PERT Consortium, a collaboration between PERTs in the United States, South America, Europe and Asia. Dr. Kabrhel is past chair of the PERT Consortium research committee and is on the PERT Consortium Board of Directors. He is also an honorary senior lecturer at Queen Mary University of London.


Clinical Interests:




Mass General Emergency Medicine: Center for Vascular Emergencies
Zero Emerson Place
Suite 3B
Boston, MA 02114
Phone: 617-726-5824

American Board Certifications

  • Emergency Medicine, American Board of Emergency Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Dr. Kabrhel's research is focused on the epidemiology, diagnosis, risk-stratification, treatment, and health policy aspects of PE and DVT. His work is funded by the NIH (R01, R21, STTR), private foundations, and industry partners. When his research into VTE began, about 15 years ago, he concentrated on topics relevant to emergency medicine and related specialties. However, over the past decade his research has expanded into areas interesting to the scientific community at large. These include multicenter clinical trials and biomarker studies, but also VTE genetics, economics, environmental epidemiology, metabolomics, and nutrition.

In addition to clinical research,  Dr. Kabrhel coordinates PE research for the two Nurses’ Health Studies (Channing Network Medicine at BWH) and Health Professionals Follow Up Study (HSPH). His early work with these cohorts was funded by an R21 from the National Heart, Lung and Blood Institute and the National Institute for Aging and resulted in several publications describing novel environmental risk factors for VTE. In 2012, he was awarded NIH/NHLBI funding (R01) to study novel genetic and environmental risk factors for VTE. As part of this grant, he co-founded the International Network for VENous Thromboembolism (INVENT) Consortium, an international collaboration focused on discovering novel genetic and epidemiological risk factors for VTE. More recently, he performed the first metabolomic studies to identify metabolites and metabolic profiles associated with VTE.



Reviews: Comments and Ratings